Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other Synucleinopathies

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

December 20, 2019

Study Completion Date

June 30, 2020

Conditions
Parkinsonian Disorders
Interventions
OTHER

V1: HGPO + meal and V2: placebo + meal

"* Ambulatory polysomnography for the night preceding each test~* Usual antiparkinsonian treatments at their usual dose and timing~* Randomisation to receive an oral solution of glucose load or a placebo (fructose). Standard meal 4 hours after the test~* During two hours following the oral solution administration and the standardized meal, we will perform the followings for each patient :~ * continuous digital blood pressure monitoring by Nexfin®~ * blood pressure monitoring at brachial artery~ * continuous polysomnographic recording~ * synchronized continuous digital audiovisual recording~ * glucose and insulin blood level monitoring Additional blood samples will be taken in order to assay the intestine-pancreatic neuropeptides including incretins GLP- 1 and GIP"

OTHER

V1: placebo 75mg + meal and V2: HGPO 75mg + meal

"* Ambulatory polysomnography for the night preceding each test~* Usual antiparkinsonian treatments at their usual dose and timing~* Randomisation to receive an oral solution of glucose load or a placebo (fructose). Standard meal 4 hours after the test~* During two hours following the oral solution administration and the standardized meal, we will perform the followings for each patient :~ * continuous digital blood pressure monitoring by Nexfin®~ * blood pressure monitoring at brachial artery~ * continuous polysomnographic recording~ * synchronized continuous digital audiovisual recording~ * glucose and insulin blood level monitoring Additional blood samples will be taken in order to assay the intestine-pancreatic neuropeptides including incretins GLP- 1 and GIP"

Trial Locations (2)

31059

UHToulouse, Toulouse

33076

UHBordeaux, Bordeaux

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

lead

University Hospital, Toulouse

OTHER

NCT02021903 - Post-prandial Hypotension and Sleepiness in Parkinson's Disease and Other Synucleinopathies | Biotech Hunter | Biotech Hunter